Smarter Decisions,
Better Care
UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point of care decisions.
For more information, click below.
Subscribers log in here
Related articles
| AuthorLeonard I Ganz, MD, FHRS, FACC | Section EditorSamuel Lévy, MD | Deputy EditorBrian C Downey, MD, FACC |
Topic Outline
INTRODUCTION
Any supraventricular tachycardia (SVT) that requires only atrial tissue for its initiation and maintenance can properly be considered an atrial tachyarrhythmia. Although a relatively uncommon form of SVT, atrial tachycardia tends to be refractory to pharmacologic therapy and is therefore frequently treated with ablative therapy.
Current catheter ablative techniques have evolved from open surgical techniques in which the arrhythmia focus was identified using intraoperative mapping and then excised [1,2]. Direct current (DC) shock catheter ablation (fulguration) was used for a short time in small numbers of patients with atrial tachycardia; this technique has been completely supplanted by radiofrequency (RF) catheter ablation.
Radiofrequency catheter ablation (RFCA) techniques and outcomes in patients with atrial tachycardia will be reviewed here. Ablative techniques for the management of atrial fibrillation, and atrial flutter, both typical and atypical flutter, are discussed separately. (See "Radiofrequency catheter ablation to prevent recurrent atrial fibrillation" and "Maintenance of sinus rhythm after cardioversion in atrial flutter".)
ATRIAL TACHYCARDIAS AMENABLE TO CATHETER ABLATION
Atrial tachycardia may be unifocal or multifocal; some unifocal tachycardias originate in or around the sinus node.
Subscribers log in here